INTRODUCTION
Nucleolin (100-110 kDa; also called C23) is a ubiquitous phosphoprotein in eukaryotic cells; predominantly localized in the nucleolus. Numerous experiments using whole animals, intact cells, isolated nuclei and nucleoli have implicated nucleolin in the regulation of rDNA transcription (Bugler et al., 1982 (Bugler et al., , 1987 Olson et al., 1983; Bouche et al., 1984; Escande et al., 1985; Gas et al., 1985; Jordan, 1987; Lapeyre et al., 1987; Erard et al., 1988; Egyhazi et al., 1988; Belenguer et al., 1989) and maturation of rRNA (Prestayko et al., 1974; Bourbon et al., 1983; Bouche et al., 1984; Herrera and Olson, 1986; Bugler et al., 1987) , although its exact role remains to be determined. The amino acid sequence found previously indicates that the protein consists of three domains (Lapeyre et al., 1986 Bourbon et al., 1988; Schneider and Issinger, 1988; Olson et al., 1990; Bourbon and Amalric, 1990; Belenguer et al., 1990) , the N-terminal domain possessing several concensus phosphorylation sites Schneider and Issinger, 1988; Belenguer et al., 1990) . The phosphorylation of nucleolin is catalysed by casein kinase II (Caizergues et al., 1987; Pfaff and Anderer, 1988; Warrener and Petryshyn, 1991) and enhances the proteolytic cleavage of nucleolin (Warrener and Petryshyn, 1991) .
We previously showed that testosterone and polyamines stimulate the phosphorylation of nucleolar proteins in rat ventral prostates and that spermine increases the degradation of nucleolin to a 59 kDa phosphopeptide by a serine-type protease (Suzuki et al., 1985) . The presence of similar peptides in nucleoli was reported also during oogenesis and embryogenesis of Xenopus laevis (Caizergues-Ferrer et al., 1989) . However, detailed studies were hampered because of the comparatively small size of rat prostates. Later, we found that phosphorylation of nucleolin as well as rRNA synthesis in liver was also controlled by a steroid, glucocorticoid, through a change in the activity of nucleolar casein kinase II (Suzuki et al., 1987 (Suzuki et al., , 1991 . On the other hand, nucleolin was reported to bind to histone HI at ing to the purified nucleolin was decreased by KCl concentrations above 50 mM, histones (H1, H2B and H3) were able to bind to the nucleolin in the presence of up to 300 mM KCl. A distinct difference between HI and other histones was found in that HI could produce p60 from nucleolin in both Nu-and Nu-2, whereas H2B and H3 stimulated the degradation of nucleolin to p60 only when Nu-2 was used for the source of nucleolin. A possible relationship between p60 formation and rRNA synthesis is discussed, but its exact role remains to be studied.
physiological ionic strength and induce chromatin decondensation (Erard et al., 1988) . Thus the present investigation was undertaken to examine whether and how spermine and histone HI enhance the limited proteolysis of nucleolin to 60 kDa phosphopeptide (p60) in liver nucleoli.
MATERIALS AND METHODS Materials
[y-32P]ATP (4500 Ci/mmol) and ['4Clspermine tetrachloride (90 mCi/mmol) were purchased from ICN Biochemicals, Irvine, CA, U.S.A. and from CEA, France, respectively. Peroxidaseconjugated goat anti-rabbit IgG antiserum was from Seikagaku Kogyo Co., Tokyo, Japan. Anti-nucleolin antiserum was prepared as described by Suzuki et al. (1991) .
Isolation of nucleoll and preparations of nucleolin-rich fraction (Nu-2) and purffled nucleolin (Nu-3)
Nucleoli were isolated from livers of male rats (Wistar strain, 150-200 g) as described previously (Suzuki et al., 1987) . From the nucleolar suspension (termed Nu-1), a nucleolin-rich fraction (termed here Nu-2) was prepared by the method of Bourbon et al. (1983) . Briefly, the nucleoli were incubated at 4°C for 30 min in the presence of 1 mM EDTA (pH 7.4), followed by centrifugation at 10000 g for 5 min. 
SDS/PAGE and immuwmblot analysis
Nu-l or Nu-2 was labelled with 32P and subjected to SDS/PAGE and transblotting as described previously (Suzuki et al., 1987) .
The proteins were then transferred to nitrocellulose mnembrane as described by Towbin et al. (1979) in a semi-dry blotting apparatus (Nihon Eido, Tokyo, Japan). The blotted membrane was then washed six times with PBS-T and incubated for 60 min in PBS containing 3 % BSA. After several washes, the membrane was incubated with 1/2000-diluted anti-nucleolin antiserum or nonimmune control serum. After six washes with PBS-T, the membrane was incubated for 1 h with peroxidase-conjugated anti-rabbit IgG antiserum. Unbound antibodies were washed out extensively with PBS-T and the blots were stained with 4-chloro-1-naphthol and H202.
Chemical cleavage of nucleolin with N-bromosuccinimide (NBS)
Chemical cleavage of nucleolin with NBS was carried out by the method of Rao et al. (1982) . A mixture (400 ul) containing 50 mM Tris/HCl (pH 7.5), 6 mM MgCl2, 1OuM [y-32P]ATP
(1 #Ci) and the Nu-2 fraction (30 ,tg of protein) was incubated at 37°C for 10 min. After addition of 133 ,ul of acetic acid (final concn. 25%, v/v), 1 mg of solid NBS was dissolved in the mixture and the chemical reaction was carried out for 60 min at room temperature. The reaction mixture was then diluted 3-fold with water, and freeze-dried.
Digestion of nucleolin and its fragments with V8 protease and peptide mapping Bands of nucleolin and its fragments on SDS/PAGE were cut protease (0.25 and 1.0 ,ug/sample well) during the second SDS/PAGE as described by Cleveland et al. (1977) .
Binding of spermine to nucleolin
The incubation mixture contained, in a total volume of 200 ,ul, Nu-3 (10 ,tg of protein), 10 ,uM ['4C]spermine (90 mCi/mmol) and 20 mM Tris/HCl (pH 7.5). After incubation for 15 min at room temperature, the mixture was applied to a PD-10 column which was previously equilibrated with Tris/HCl buffer (pH 7.5), and washed with 5 ml of the same buffer. The buffer was then changed to 0.1 M HCI containing 0.5 M NaCl, and radioactivity was measured in each fraction (0.5 ml) obtained. In parallel experiments, 50 mM KC1 or 1 mM spermine (non-radioactive) was added to the incubation mixture.
Binding of nucleolin to histones
Binding of nucleolin to histone H1 was examined with a Hiaffinity column (Erard et al., 1988) , and with nitrocellulose membranes bound to HI. The histone HI column was prepared by coupling histone HI with CNBr-activated Sepharose 4B and equilibrating with 20 mM Tris/HCl (pH 7.5) containing 1 mM EDTA, 1 mM fl-mercaptoethanol, 0.5 mM PMSF, 30 % glycerol and 50 mM KCI. The Nu-3 fraction phosphorylated as mentioned above was dialysed against the equilibrium buffer and applied to the column. After the column had been washed with 5 ml of the same buffer, nucleolin was eluted with a linear gradient of KCI (0.05-1.0 M). A portion of each fraction was subjected to SDS/PAGE, followed by Coomassie Blue staining. The remaining part of each fraction was used for measurement of 32P radioactivity. The binding experiments with nitrocellulose membranes were carried out as follows. After histone H 1 (2 ,ug/well) was spotted with a slot-blotter (Dassel, Germany) on to the nitrocellulose membrane, the membrane was incubated for 1 h at room temperature in the binding buffer (20 mM Tris/HCl, pH 7.5, 1 mM EDTA, 0.2% Ficoll 400, 0.2% polyvinylpyrrolidone and 0.2 % BSA), and then for 3 h in the same buffer containing 32P-labelled Nu-3 (1 ,tg of protein/slot), lysozyme (200 ,ug/well) and various concentrations of KCI (50-450 mM). Subsequently, the membrane was washed extensively with the binding buffer containing the corresponding concentrations of KCI, and subjected to autoradiography. The binding of H2B and H3 to nucleolin was carried out similarly.
Determination of protein, DNA and RNA contents
The protein concentration was determined by the dye-binding method described by Bradford (1976) , with ovalbumin as the standard. The concentrations of DNA and RNA were determined by the methods of Burton (1956) and Schneider (1945) Nucleolin-rich fraction (Nu-2) was prepared by extraction with 1 mM EDTA from Nu-1. The Nu-2 (0.1 mg/ml) was incubated at 37°C with [y-32P]ATP for the time intervals indicated in the absence (lanes 1 and 2) or presence of spermine (lanes 3-6). At the end of incubation, sample was subjected to SDS/PAGE, followed by protein staining (a) and autoradiography (b The above experiments were carried out with nucleolar suspension (Nu-1). Since spermine affects solubilization of nucleolar proteins by changing the structure of the nucleoli, some of these accompanying proteins might affect the proteolysis of nucleolin. We have therefore attempted to study the effect of spermine with a nucleolin-enriched preparation (Nu-2). The preparation was obtained by treatment with 1 mM EDTA for nucleolar suspension (Nu-l) (Bourbon et al., 1983) , and its nucleolin content actually reached about 50% of total proteins, another entity being the 37 kDa peptide (lane 1, Figure 2a) . Incubation of Nu-2 without spermine under phosphorylation conditions for 10 min and 120 min clearly shows the phosphorylation of nucleolin (lane 1, Figure 2b ) and of 60 and 42 kDa peptides (arrowheads, lane 2, Figure 2b) The direct binding of nucleolin to spermine was examined as described in the Materials and methods section by using purified nucleolin (Nu-3; 95 % pure, nucleic acid-free). From these experiments it was found that the binding really occurs under the conditions mentioned above, but is abolished in the presence of 50 mM KCI. Thus it is unlikely that the binding of nucleolin to spermine takes a role in the metabolism in vivo. Nu-l (1 mg/ml) was incubated for 120 min at 37°C with [32P]ATP and in the presence of Hi (lanes 4-6), H2B (lanes 7-9) and H3 (lanes 10-12) as indicated. As control experiments, the Nu-1 was incubated for 10 min (lane 1) or 120 min (lanes 2 and 3) without histones under phosphorylation conditions. Spermine (1 mM) was present in the incubation of lane 3. (Olson et al., 1983; Jordan, 1987; Erard et al., 1988; Zlatanova, 1990) . We therefore examined whether histone HI exerts any effect on the degradation of nucleolin under similar conditions. As with polyamines, the incubation of Nu-1 or Nu-2 with histone HI of lower concentrations also caused the stimulation of limited proteolysis and stabilization of nucleolin. Then we compared the effects of three histones on the limited degradation of nucleolin. Figure 3 shows the results obtained when Nu-1 was used as the source of nucleolin. It is clear that the preferential degradation of nucleolin to p60 was found in the presence of HI, but not in the presence of H2B and H3. However, the degradation of nucleolin to p60 was observed also with H2B and H3 when Nu-2, instead of Nu-1, was incubated in these histones (results not shown).
The interaction of histone HI with highly purified nucleolin (Nu-3) was studied with a histone HI affinity column, as shown in of Figures 2a and 2b) . The degradation of nucleolin was, however, diminished by using higher concentrations of spermine (lanes 4-6, Figures 2a and 2b) . It was also noticed that incubation for 120 min in the absence of spermine produced a 59 kDa peptide (arrow, lane 2 of Figure 2a ) which is likely different from p60, since it is not phosphorylated under our phosphorylation conditions. Characterization of the endogenous protease and its product (p60) from nucleolin It was previously reported that nuclei contain two kinds of proteases, thiol-type and serine-type, whose activities were high at acidic and at neutral pH, respectively (Chong et al., 1974; Tsurugi and Ogata, 1980) . In order to find which protease is responsible for the degradation of nucleolin, the effect of protease inhibitors on the degradation of nucleolin was examined. In Figure 5 , 32P-labelled Nu-2 fraction was incubated at pH 7.5 in the presence of leupeptin (lanes 2 and 3) or at pH 5.5 with PMSF (lanes 4 and 5) to inhibit thiol-type or serine-type protease, respectively, in the absence (lanes 2 and 4) or presence (lanes 3 and 5) of spermine. Stabilization of nucleolin by spermine was observed under both acidic and neutral conditions. On the other hand, 42 kDa phosphoprotein, which was observed in the absence of spermine, and spermine-dependent p60 (lanes 2) appeared under neutral conditions. These results indicate that spermine interacts with nucleolin at lower pH as well as at neutral pH, and that degradation ofnucleolin to p60 and 42 kDa phosphopeptides was catalysed by serine-type protease, which was still associated with nucleolin in the preparation in the presence of spermine. The results also showed that the degradation of nucleolin to 59 kDa peptide mentioned above (Figure 2) was not inhibited by PMSF and leupeptin, but was inhibited by spermine (see small arrows in Figure 5a-1) .
The effects of protease inhibitors on the degradation of nucleolin were examined also in the presence of histone HI
I1
Limited proteolysis of nucleolin 7.5 5.5 Figure 5 Characterization of proteases working on the proteolysis of nucleolin (a) Influence of spermine and inhibitors. The 32P-labelled Nu-2 fractions (100 ,ug/ml) were incubated for 120 min at 37°C in Tris/HCI buffer (pH 7.5) containing leupeptin (40 'Ug/mI) (lanes 2 and 3) or Tris/acetate buffer (pH 5.5) containing PMSF (1 mM) (lanes 4 and 5), in the absence (lanes 2 and 4) or presence of 1 mM spermine (lanes 3 and 5), followed by SDS/PAGE (a-1) and autoradiography (a-2). As a control, the 32P-labelled Nu-2 was subjected directly to SDS/PAGE (lane 1 1 and 3) or for 60 min at room temperature with NBS (lanes 2 and 4), followed by SDS/PAGE and then Coomassie Blue staining (lanes 1 and 2) or autoradiography (lanes 3 and 4). (b) Nu-2 fraction labelled with [y_32P]ATP was treated as mentioned above, and the bands corresponding to p60 produced by endogenous proteases (lanes 3 and 5) and by NBS (lanes 4 and 6) were cut out from the gel, and peptide-mapping analysis using V8 protease was carried out as described in the Materials and methods section. As control experiments, the nucleolin band prepared from 32P-labelled Nu-2 was treated with V8 protease, followed by SDS/PAGE (lanes 1 and 2). The amounts of V8 protease employed were 0.25 ,tg (lanes 1, 3 and 4) and 1.0 ,g (lanes 2, 5 and 6).
( Figure 5b ): H 1-stimulated degradation of nucleolin to p60 is 6), it is likely that p60 is almost identical with the NBS-produced abolished by inhibitors of serine-type proteases (see lanes 7 and 60 kDa peptide of Rao et al. (1982) . 8).
To determine the location of p60 in the parent molecule, the DISCUSSION electrophoretic mobility and V8-protease-treatment pattern of p60 were compared with those of the N-terminal half of nucleolin, Recent studies on the primary structure of nucleolin have which was produced with NBS treatment, possessing all of the indicated that the protein consists of three domains, as shown in phosphorylation sites (Rao et al., 1982) . From the results ( Figure  Figure 7 (Lapeyre et al., 1986 Bourbon et al., 1988; Figure 7 Schematic representation of nucleolin primary structure
The N-terminal one-third consists of acidic regions (A-D) and lysine-rich segments (K1-K5). The central domain is composed of four closely related 90-residue segments (R1-R4). The C-terminal domain contains approx. 60 residues. Arrowheads indicate the sites phosphorylated by casein kinase 11, and arrows show the number in the sequence. DMA, dimethylarginine. et al., 1990; Bourbon and Amalric, 1990) . It is considered that the first domain, containing an N-terminal (about 300 residues), is elongated and binds to histone HI with its acidic regions (A-D) and to DNA with its basic regions (K1-K5), whereas the central domain, composed of four closely related 90-residue sections, is a relatively compact unit interacting with RNA, and the C-terminal domain (approx. 60 residues, enriched in glycine and dimethylarginine) is of a non-globular conformation (Olson et al., 1990) . The N-terminal portion of nucleolin in which phosphorylation sites reside Caizergues-Ferrer et al., 1987) is known to be highly susceptible to proteolysis (Olson et al., 1990 ). Thus phosphorylated nucleolin (100-110 kDa) of rat liver was cleaved on incubation at 37°C to 90 kDa, 80 kDa and especially 60 kDa phosphopeptides and then further to smaller peptides (Figures 1 and 2 ). The present study showed that 1 mM spermine protected the 60 kDa phosphopeptide (p60) from further degradation, as found previously in prostatic tissues (Suzuki et al., 1985) . Similar actions were also found with spermidine and putrescine at higher concentrations and in the presence of histones of much lower concentrations.
The p60 peptide is considered to have the same N-terminal end as the parent protein, since it was immunologically related to nucleolin, having phosphorylation sites (Figure 1) , and is almost identical with the 60 kDa peptide produced by the treatment with NBS ( Figure 6 ) found by Rao et al. (1982) . The C-terminal amino acid was not determined in both peptides. However, the treatment with NBS under their conditions is considered to cleave tyrosine bonds of nucleolin (Rao et al., 1982) , and the most plausible end may be Tyr-436 or Tyr-465, on the basis of the molecular size of the peptide and the sequence of rat nucleolin (Bourbon and Amalric, 1990) . These tyrosine residues are located in the area between R2 and R3 (arrows, Figure 7) , which is known to be susceptible to trypsin and chymotrypsin (Olson et al., 1990) . It is tempting to assume that the formation of p60 from nucleolin was derived by the attack of an endogenous protease on the exposed area of nucleolin, the other parts of which are protected by histones, DNA and RNA.
The protease responsible for the cleavage of liver nucleolin to p60 was found to be a serine-type enzyme (Figure 5 ), as in the prostate (Suzuki et al., 1985) . In addition to the enzyme, liver seems to contain also a thiol-type protease, which produces a 59 kDa peptide with no phosphorylation site. It is not clear, however, whether this enzyme is related to the thiol-type protease in Chinese-hamster ovary cells reported previously by Bourbon et al. (1983) , since no information was given about the phosphorylation of their product (60 kDa).
The physiological significance of proteolytic degradation of nucleolin to p60 in liver remains to be determined. The formation of smaller peptides (50 and 48 kDa) from nucleolin was found in Xenopus laevis oocytes from stages I-III and related to transcription of rDNA (Caizergues-Ferrer et al., 1989) . In Chinesehamster cells, the synthesis of pre-rRNA is inhibited by the protease inhibitor leupeptin, and this was also interpreted by the participation of a nucleolin maturation process in the rDNA transcription (Bouche et al., 1984) . Although the present results were obtained in experiments in vitro, it is noteworthy that the preferential formation of p60 from nucleolin was observed on incubation with histone HI, but not H2B and H3, when Nu-1 was used as nucleolin source (Figure 3 ). Nu-1 (isolated nucleoli) are considered to reflect the state in vivo more than Nu-2, which was obtained after treatment with EDTA, being separated from nucleolar chromatin and associated proteins. Histone HI is known to bind to linker DNA and inhibit transcription (Weintraub, 1984; Zlatanova, 1990) . It was also reported that nucleolin is capable of inducing chromatin decondensation by displacing HI from chromatin by interacting with the C-terminal part of HI (Erard et al., 1988) . On the other hand, the phosphorylation of nucleolin was catalysed by casein kinase II in many tissues (Caizergues-Ferrer et al., 1987; Suzuki et al., 1987; Saito et al., 1988; Schneider and Issinger, 1988) , and that the phosphorylation of nucleolin in 3T3-F442A cells enhanced its proteolytic degradation to 30 kDa and 72 kDa peptides (Warrener and Petryshyn, . The activities of casein kinase II and rRNA synthesis were found to be dependent on hormonal stimulus in hepatocytes (Suzuki et al., 1987) and lymphosarcoma P1798 (Suzuki et al., 1992 ) and on cell growth in HeLa cells (Schneider and Issinger, 1989) . These facts raise the possibility that the phosphorylation of nucleolin and its preferential degradation to p60 or other smaller peptides may be something to do with pre-rRNA synthesis and maturation of rRNA. Further studies with intact cells are needed to inspect this hypothesis concerning the formation of the smaller peptides from nucleolin.
